Evidence map›Paper›PMID 37921487›Full record

ArticleChemical communications (Cambridge, England)2023

A ribose-functionalized NAD

Elisa N Stephens, Xiao-Nan Zhang, Albert T Lam, Jiawei Li, Hua Pei, Stan G Louie, Clay C C Wang, Yong Zhang

Open access · greenAbstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. PAR-Driven Condensation Maintains Stalled Replication Fork Stability.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. An NADTetrahedron · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Elisa N StephensDepartment of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA. yongz@usc.edu.ORCID http://orcid.org/0000-0001-6773-6475
Xiao-Nan ZhangDepartment of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA. yongz@usc.edu.ORCID http://orcid.org/0000-0002-9780-6507
Albert T LamDepartment of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA. yongz@usc.edu.
Jiawei LiDepartment of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA. yongz@usc.edu.
Hua PeiTitus Family Department of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA.
Stan G LouieTitus Family Department of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA.
Clay C C WangDepartment of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA. yongz@usc.edu.ORCID http://orcid.org/0000-0003-2955-7569
Yong ZhangDepartment of Pharmacology and Pharmaceutical Sciences, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089, USA. yongz@usc.edu.ORCID http://orcid.org/0000-0002-3132-8557
University of Southern California · US

Funding

Chemistry and Biology of ADP-Ribosylation-Dependent SignalingR35GM137901 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Yong Zhang · 2020 to 2026
$2.5M
Reprogramming Exosomes for Biomedical ApplicationsR01EB031830 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZHANG, YONG · 2021 to 2024
$2.1M
Reprogramming Exosomes for Novel Immunotherapy of Triple Negative Breast CancerR01CA276240 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Yong Zhang · 2023 to 2026
$2.0M
NCI NIH HHS R01 CA276240NIBIB NIH HHS R01 EB031830NIGMS NIH HHS R35 GM137901
6 · The paper itself

Abstract

An NAD

Indexed as

NADRiboseADP Ribose TransferasesADP-RibosylationPoly(ADP-ribose) PolymerasesADP Ribose TransferasesNADPoly(ADP-ribose) PolymerasesRibose

Identifiers

PMID37921487
PMCPMC10841986
OpenAlexW4388303003

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.